The 52-week high and low prices can offer valuable insights into a stock’s current standing and prospects for future performance. TG Therapeutics Inc.’s current trading price is -72.81% away from its 52-week high, while its distance from the 52-week low is 99.59%. The stock’s price range for this period has been between $4.86 and $35.67 The company’s shares, which are part of the Healthcare sector, had a trading volume of approximately 2.51 million for the day, a number notably lower than the average daily volume of 4.98 million over the last three months.
At present, TG Therapeutics Inc. (TGTX) has a stock price of $9.70. In the previous session, the stock saw a rise, peaking at $10.311 after an opening price of $10.19. The day’s lowest price was $9.97, and it closed at $10.14.
In today's chaotic marketplace, the biggest gains will come from some currently-small companies that pass by older, larger businesses still stuck in a pre-pandemic world. The trick is figuring out which small caps will be tomorrow's winners. That's why StockWire News has put together a special Wealth Building Report, highlighting 3 small cap stocks set to soar in 2023.
Click here for full details and to join for free
TG Therapeutics Inc. ‘s stock market performance has been somewhat predictable. The company’s stock reached a 1-year high price of $35.67 on 05/04/23, while the lowest value for the same period was recorded at $4.86 on 10/21/22.
Exploring Financial Performance and Market Capitalization: A Comprehensive Analysis
TG Therapeutics Inc. (TGTX) has experienced a quarterly decline of -62.21% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 1.47B and boasts a workforce of 244 employees.
Analyzing Trading Volume and Moving Average Trends
Based on Barchart.com data, the company’s moving average over the 100-day period was 20.81, with a change in price of -12.71. Similarly, TG Therapeutics Inc. recorded 4,676,658 in trading volume during the last 100 days, posting a change of -56.81%.
Understanding Ticker ‘s Debt-to-Equity Ratio: An Analysis
The debt-to-equity (D/E) ratio serves as an important indicator of a company’s financial stability and market position. By dividing a company’s total liabilities by its shareholders’ equity, the D/E ratio reveals the degree to which a company relies on debt to finance assets compared to its shareholders’ equity. At the time of writing, the total D/E ratio for TGTX stands at 2.41. Similarly, the long-term debt-to-equity ratio is also 2.41.
TGTX Stock Stochastic Average
TG Therapeutics Inc.’s raw stochastic average for the past 50 days is presently 2.89%, as of today. This marks a decrease from the raw stochastic average of the last 20 days, which was 14.95%. Additionally, the company’s Stochastic %K and %D values for the past 20 days were 13.05% and 14.35%, respectively.
TGTX Stock Price Performance Analysis
Investors’ outlook regarding the stock price performance over the year has been a mixed bag, with a range of optimism to pessimism depending on their perspective. Year to date metric has recorded a loss of -18.01%.However, over the last six months, we can see a stronger performance of -34.42%. Over the last 30 days, the price of TGTX has leaped by -6.64%. And in the last five days, it has fallen by -8.66%.
